Our solutions
Technology that advances care.
A selective portfolio of clinically meaningful healthcare technologies, supported by credible commercialization and consultative partnership.
01
Point of Care Diagnostics
FebriDx®
FebriDx® is a rapid, single-use point-of-care immunoassay that detects the host response proteins MxA and C-reactive protein from a fingerstick blood sample. FebriDx® test results are intended to be used in conjunction with other clinical and diagnostic findings as an aid in the diagnosis of bacterial acute respiratory infection and differentiation from non-bacterial etiology.Explore FebriDx® resources
Enterprise Digital Healthcare
LiifeID
Explore LiifeID for hospitals and clinics, available through NorthStar’s partnership with Mazon Medical.Explore LiifeIDA disciplined portfolio
Chosen for relevance. Represented with rigor.
Clinical utilitySolutions selected for a meaningful role in real care environments.
Scientific fluencyEvidence and education translated into credible provider conversations.
Commercial readinessMarket strategy grounded in healthcare operations and buying behavior.
Portfolio inquiries
Looking for a specific solution?
Let's talk about your clinical setting, priorities, and path forward.